US FDA declines to approve GSK drugs division’s long acting HIV injection
ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » GSK
Browsing Tag
GSK
Chiron Behring re-launches its rabies vaccine as ‘Chirorab’
Chiron Behring Vaccines was acquired by Bharat Biotech from GSK in March 2019 and commercial operations were restarted in May 2019
After sartans and ranitidine, where will NDMA show up next?
While regulators and pharma companies try to understand if it is the product or the process that is at fault in the ranitidine…
GSK announces tuberculosis vaccine Phase IIb Trial results
The Indian government has made the fight against TB a central priority and boldly pledged to end TB by 2025, five years before the…
GSK to sell two vaccines in $1.1 billion deal to focus on newer treatments
The sale of anti-rabies treatment Rabipur and Encepur to the Denmark-based biotechnology firm includes an upfront payment of 301…
Teva’s UK arm recalls some batches of Ranitidine: Medicines watchdog
Teva, the world's largest generic drugmaker, is recalling all unexpired stock of Ranitidine Effervescent Tablets in 150 micrograms…
Big Pharma to get bigger, but what about patients?
The second patent cliff is around the corner, as patents for branded molecules with cumulative global sales of over $ 251 billion…
GSK will invest up to £600k to support ‘Trust in Science’ initiative
Pharma major GlaxoSmithKline Pharmaceuticals (GSK) has launched ‘Trust in Science’ initiative in partnership with the Regional…
GSK and Regional Centre for Biotechnology to develop PhD programs in biostatistics and…
The programme cover scholarship and expert guidance for completion of doctoral degrees
programs to equip students with high-end…
GSK Pharma strengthens vaccine portfolio
GST implementation impacts GSK's June quarter performance